Nanoviricides Inc (NNVC)
1.91
-0.01
(-0.52%)
USD |
NYAM |
Jun 25, 16:00
1.85
-0.06
(-3.14%)
After-Hours: 20:00
Nanoviricides 30-Day Average Daily Volume: 391731.1 for June 25, 2024
30-Day Average Daily Volume Chart
Historical 30-Day Average Daily Volume Data
| Date | Value |
|---|---|
| June 25, 2024 | 391731.1 |
| June 24, 2024 | 382119.4 |
| June 21, 2024 | 386491.5 |
| June 20, 2024 | 405126.1 |
| June 18, 2024 | 404691.4 |
| June 17, 2024 | 432669.4 |
| June 14, 2024 | 425761.0 |
| June 13, 2024 | 403115.3 |
| June 12, 2024 | 385873.3 |
| June 11, 2024 | 363030.8 |
| June 10, 2024 | 342271.2 |
| June 07, 2024 | 310215.1 |
| June 06, 2024 | 304994.7 |
| June 05, 2024 | 265862.9 |
| June 04, 2024 | 259960.7 |
| June 03, 2024 | 255733.0 |
| May 31, 2024 | 251090.2 |
| May 30, 2024 | 246308.3 |
| May 29, 2024 | 241461.7 |
| May 28, 2024 | 222798.3 |
| May 24, 2024 | 221580.5 |
| May 23, 2024 | 214237.0 |
| May 22, 2024 | 203206.7 |
| May 21, 2024 | 194477.1 |
| May 20, 2024 | 187565.2 |
| Date | Value |
|---|---|
| May 17, 2024 | 182584.3 |
| May 16, 2024 | 177330.8 |
| May 15, 2024 | 162509.5 |
| May 14, 2024 | 151042.0 |
| May 13, 2024 | 129938.7 |
| May 10, 2024 | 129200.9 |
| May 09, 2024 | 123552.0 |
| May 08, 2024 | 105998.3 |
| May 07, 2024 | 82827.83 |
| May 06, 2024 | 66099.47 |
| May 03, 2024 | 31954.73 |
| May 02, 2024 | 32051.53 |
| May 01, 2024 | 33100.37 |
| April 30, 2024 | 33211.67 |
| April 29, 2024 | 31526.77 |
| April 26, 2024 | 31825.17 |
| April 25, 2024 | 33049.17 |
| April 24, 2024 | 33088.53 |
| April 23, 2024 | 33164.43 |
| April 22, 2024 | 33583.83 |
| April 19, 2024 | 33550.37 |
| April 18, 2024 | 33370.23 |
| April 17, 2024 | 34154.70 |
| April 16, 2024 | 34573.23 |
| April 15, 2024 | 35235.63 |
30-Day Average Daily Volume Range, Past 5 Years
3962.80
Minimum
Aug 28 2019
8.082M
Maximum
Mar 03 2020
689330.3
Average
83499.62
Median
30-Day Average Daily Volume Benchmarks
| EyePoint Pharmaceuticals Inc | 917036.3 |
| Enanta Pharmaceuticals Inc | 162824.5 |
| GlycoMimetics Inc | 5.007M |
| FibroGen Inc | 1.923M |
| Corvus Pharmaceuticals Inc | 200046.9 |